Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
RadNet, Inc. | RDNT | 4.85M | $298.91M |
Immunocore Holdings plc | IMCR | 4.87M | $154.62M |
Protagonist Therapeutics, Inc. | PTGX | 5.06M | $620.4M |
Stoke Therapeutics, Inc. | STOK | 5.62M | $184M |
Verastem, Inc. | VSTM | 6.64M | $25.35M |
Ocugen, Inc. | OCGN | 6.67M | $10.2M |
Xencor, Inc. | XNCR | 6.78M | $109.12M |
ACADIA Pharmaceuticals Inc. | ACAD | 7.14M | $180.76M |
Replimune Group, Inc. | REPL | 7.41M | $82.05M |
Aquestive Therapeutics, Inc. | AQST | 7.43M | $30.89M |
PTC Therapeutics, Inc. | PTCT | 7.75M | $631.88M |
Ultragenyx Pharmaceutical Inc. | RARE | 7.8M | $260.34M |
CG Oncology Inc. | CGON | 8.51M | $604.96M |
COMPASS Pathways plc | CMPS | 10.7M | $151.42M |
Kailera Therapeutics, Inc. | KLRA | 10.78M | $237.41M |
Tango Therapeutics, Inc. | TNGX | 13.9M | $434.53M |
Rocket Pharmaceuticals, Inc. | RCKT | 17.69M | $60.49M |
Erasca, Inc. | ERAS | 17.95M | $328.78M |